EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 11 December 2025

EFPIA response to pharmaceutical package agreement: More to do to keep European pharma competitive

Read more here.

The conclusion of the pharmaceutical package by the European Union is a significant moment in shaping the future of one of Europe’s most strategically important sectors, supporting the health and economic security of Europe and impacting patient care for decades.

While the package contains signals that the EU recognises the importance of the legislation as a key driver of competitiveness for the innovative pharmaceutical sector in Europe, it is not strong enough to move the needle on European competitiveness – a key objective of this Commission.

If Europe truly wants to be competitive it needs to increase investment in innovative medicines, strengthen rather than weaken IP and make the process of getting new medicines to patients faster and more connected.

Environmental omnibus to deliver EU simplification agenda fails to address unworkable UWWTD...
10 December 2025

EFPIA reiterates its call for the suspension of Articles 9 and 10 and Annex III of the UWWTD pending a proper assessment... Read more

Advancing Environmental Sustainability Assessment of Pharmaceuticals through Standardisation...
10 December 2025

EFPIA acknowledges the interest in having product environmental data to support climate goals, and member companies... Read more

AI Across the Medicines Lifecycle: Insights from Preliminary Case Studies and Considerations...
09 December 2025

As AI becomes more deeply embedded in regulatory decision-making and processes that impact patients, the need for robust... Read more

EFPIA calls for a balanced approach to Economic Security that builds on the strength of Europe’s...
05 December 2025

The research-based pharmaceutical sector is a critical strategic security asset and the highest contributor to the EU... Read more

EACH Cardiovascular Health Summit 2025: Highlights from Brussels

On 10-11 December, the EACH Cardiovascular Health Summit 2025 gathered policymakers, researchers, patients, and health leaders in Brussels to advance a shared vision for improved cardiovascular health across Europe.

The two-day event marked a historic moment for the cardiovascular community, with the imminent adoption of the EU Cardiovascular Health Plan.

Learn more here.

What we are reading

Pharma package: EU seals deal on overhaul of two-decade-old medicines law
On 11 December 2025 (Euractiv)

Under the agreement, companies will receive a stable eight-year data protection period during which rivals cannot... Read more

Beyond tariffs: Trump’s pricing rule worries a Novartis executive more
On 08 December 2025 (Euractiv)

Novartis executive Patrick Horber says Europe’s access and innovation rules worry him more than Trump’s tariff threats.

Health system: the value of care and the pharmaceutical industry
On 01 December 2025 (Sky TG24)

Sky TG24’s in-depth feature dedicated to the value of care and the pharmaceutical industry. A six-part series that... Read more

iCARE4CVD: Individualised care from early risk of cardiovascular disease to established heart...
On 01 December 2025 (IHI)

The iCARE4CVD project developed an AI-based tool to harmonise cardiovascular health data across different healthcare

EFPIA President: Europe needs mindset shift and decisive action to reclaim its leadership in...
On 27 November 2025 (Business Review)

Europe is at a turning point for global competitiveness. As the life sciences landscape shifts rapidly, the choices... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu